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Each year cardiovascular disease is the leading cause of 
death globally (WHO 2011). An estimated 17.1 million 
deaths were attributed to cardiovascular disease in 2004, 
representing 29% of all deaths worldwide. Of these deaths, 
an estimated 7.2 million were due to coronary heart disease 
and 5.7 million due to stroke. Cardiovascular disease is 
projected to remain the single leading cause of death in the 
future (WHO 2011) and is a priority health area for research 
and for evidence translation.
The greatest proportion of the burden of cardiovascular 
disease in Australia is attributable to cardiac conditions, 
predominantly coronary heart disease and heart failure 
(AIHW 2011). Myocardial infarctions are a common 
manifestation of these conditions. People who survive an 
acute myocardial infarction and those with chronic cardiac 
disease are at high absolute risk of recurrence and death 
(Fox et al 2010, Krempf et al 2010). Options for reducing 
this risk include medications, revascularisation procedures, 
and secondary prevention and rehabilitation programs 
(Briffa et al 2009).
The reduction of modiﬁable cardiovascular risk is an 
important aim in the management of cardiac patients. 
Behavioural risk factors such as unhealthy diet, physical 
inactivity, and tobacco use are responsible for the majority 
of coronary heart disease, and may contribute to increased 
blood pressure, raised blood glucose levels, dyslipidaemia, 
and overweight and obesity (WHO 2011). Despite this, 
in a recent examination of 18 809 patients after an acute 
coronary event, only 30% were adhering to diet and exercise 
recommendations and only 70% had quit smoking (Chow et 
al 2010). This highlights the vast scope for physiotherapists 
to join other researchers, clinicians, and policy-makers in 
improving management of cardiovascular disease.
Clinical role of physiotherapy in cardiac disease 
management
The potential role for physiotherapists in the clinical 
management of people with cardiac conditions is extensive 
and diverse. Interventions span acute and chronic care, 
involvement in primary and secondary prevention 
programs, and implementation of strategies aimed at 
reducing modiﬁable risk factors (Pryor and Prasad 2008). 
Physiotherapists are not only skilled in the assessment of 
physical activity, activities of daily living, musculoskeletal 
integrity, and quality of life, but they can also assess other 
cardiovascular risk factors such as blood pressure and body 
mass index, as well as absolute cardiovascular risk. In 
addition, physiotherapists’ understanding of multiple body 
systems allows them to account for the impact of co-morbid 
conditions when developing cardiovascular management 
plans, eg, physical activity management plans for patients 
who have co-existing musculoskeletal conditions or 
breathlessness.
Cardiorespiratory Physiotherapy Australia is a clinical 
group of the Australian Physiotherapy Association that aims 
to promote the role of physiotherapy in the management of 
both acute and chronic cardiorespiratory conditions (APA 
2011). ‘Cardiorespiratory physiotherapists’ manage diverse 
cardiac and respiratory conditions in a range of inpatient and 
outpatient clinical areas, from intensive care to outpatient 
pulmonary and cardiac rehabilitation (APA 2011). These 
clinicians may work in acute adult and paediatric hospitals, 
rehabilitation and community health centres, private 
practice, and academic environments.
The physiotherapy management of cardiac disease 
is largely focussed on therapeutic exercise. Reviews 
examining the beneﬁt of therapeutic exercise have found 
high-level evidence that therapeutic exercise is beneﬁcial 
for patients across broad areas of physiotherapy practice, 
including people with coronary heart disease (Taylor et al 
2007). Furthermore, individualised exercise programs may 
be more beneﬁcial than standardised programs (Taylor 
et al 2007). However, whilst the role of physiotherapy in 
therapeutic exercise and assessment is widely accepted, 
the capacity of physiotherapists to participate in and co-
ordinate other behavioural strategies for cardiac disease 
management is also of key importance. Recent studies 
relating to physiotherapy strategies for people with diabetes 
(Ng et al 2010, Irvine et al 2009), chronic heart failure 
(Hwang et al 2010), and coronary disease (Redfern et al 
2009) have also been documented. In addition, other studies 
highlight the integration of musculoskeletal training with 
strategies aimed to relieve shoulder (Reeve et al 2010) and 
sternal pain after thoracotomy (El-Ansary et al 2007).
Overall, physiotherapists are highly trained health 
professionals, are comfortable working as part of a 
multidisciplinary team and have extensive training in 
behaviour modiﬁcation. This makes physiotherapists 
well placed to supervise individual health management 
programs that focus on risk factors for coronary disease and 
to be involved in and lead high-quality scientiﬁc research in 
cardiac disease.
Cardiac disease research and physiotherapists
Despite the extensive burden of cardiac disease on the 
health of people across the globe and the ideal training of 
physiotherapists in the area of prevention and management, 
our impression is that little Australian cardiology 
research is being led by physiotherapists. To investigate 
this more objectively, we examined the engagement of 
physiotherapists in cardiology research in terms of outputs 
such as peer-reviewed publication, conference presentation 
and participation, and level of physiotherapist membership 
of relevant Australian professional organisations. We 
reviewed recent abstracts at national meetings and contacted 
professional organisations to determine membership by 
physiotherapists.
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Publications: To obtain a snapshot of physiotherapist 
engagement in peer-reviewed publications, we obtained 
a random sample of 100 cardiac-related published trials 
registered on the PEDro database. We examined each paper 
in detail to determine the profession of the authors. Where 
relevant information was not obtained on the paper itself, 
we searched the Internet or contacted the corresponding 
author for clariﬁcation. Through this process we found that, 
of the 100 trials reviewed, only one included an author who 
was identiﬁed as having a qualiﬁcation in physiotherapy. We 
also reviewed all papers in Australian cardiology journals 
over the period 2006–2010. During that ﬁve-year period, 
only three papers listed a physiotherapist as an author: one 
in Heart Lung and Circulation and two in the Medical 
Journal of Australia.
Professional membership: Another way to assess the 
engagement of physiotherapists in cardiovascular research 
is by the number of physiotherapists who are members of 
professional organisations specialising in cardiology and 
cardiovascular disease management. We contacted the two 
major professional organisations of this kind in Australia: 
the Cardiac Society of Australia and New Zealand (CSANZ) 
and the Australia Cardiovascular Health and Rehabilitation 
Association (ACRA). CSANZ is the professional society for 
cardiologists and those working in the area of cardiology 
including researchers, scientists, cardiovascular nurses, 
allied health professionals, and other healthcare workers. 
ACRA is a peak body that provides support and advocacy for 
multidisciplinary health professionals to deliver evidence-
based best practice across the continuum of cardiovascular 
care. While both actively promote membership by allied 
health professionals, including physiotherapists, and 
both provide numerous beneﬁts, membership in both 
organisations by physiotherapists is typically very low.
There are currently 1965 members of CSANZ of which 
702 (36%) are afﬁliate or non-cardiologist members. 
Surprisingly, only 8 (1% of afﬁliate members) of these 
identify themselves as physiotherapists. In contrast, 384 
(55% of afﬁliate members) identify as registered nurses. 
There are currently 460 members of ACRA, with only 43 
(9%) identifying themselves as physiotherapists. These data 
are somewhat disturbing given that most hospitals employ 
physiotherapists to work on cardiology wards, most cardiac 
rehabilitation programs include a physiotherapist as an 
integral member of the multidisciplinary team, and many 
physiotherapists working in the community would manage 
patients on a daily basis with, or at risk of, cardiac disease.
Conference participation: The respective national annual 
scientiﬁc meetings of CSANZ and ACRA provide for 
participation and presentation by a variety of health 
professionals, including physiotherapists. At the CSANZ 
conferences in 2009 and 2010 there were a total of 2310 
and 2062 registrants respectively and a total of 700 and 655 
abstracts presented respectively. A review of the registrant 
database indicates that less than ﬁve physiotherapists were 
identiﬁed as registering for each of the annual conferences. 
A review of the ACRA Proceedings for 2003–2007 found 
a total of 279 abstracts were presented over the ﬁve-year 
period (Fernandez et al 2011). Detailed analysis of author 
profession, independent of order listed, found that only 13 
(5%) were presented by physiotherapists over the ﬁve-year 
period examined. Of those presented by a physiotherapist, 
only one was subsequently published in a peer-reviewed 
journal. In comparison, 107 (38%) abstracts were 
authored and presented (six subsequent peer-reviewed full 
manuscripts) by registered nurses.
The biennial Cardiorespiratory Physiotherapy Australia 
meeting is part of APA Conference and is the major meeting 
that speciﬁcally targets Australian physiotherapists. 
Therefore, the conference proceedings for the 
Cardiorespiratory Stream at the conferences in 2007, 2009, 
and 2011 were reviewed. Of the abstracts presented at the 
three conferences, only 8% (SD 4%) were related to cardiac 
conditions. In comparison, 60% (SD 13%) were related to 
respiratory disease. The difference between cardiac and 
respiratory abstracts was much less extreme at the recent 
World Physical Therapy meeting. In this forum, 31 abstracts 
related speciﬁcally to cardiac disease (among a much larger 
cohort of abstracts on lifestyle disease prevention generally), 
compared to 42 abstracts related speciﬁcally to respiratory 
disease.
It is possible that physiotherapy research is being conducted 
and published outside traditional physiotherapy journals 
and conferences, or that physiotherapists working in 
non-clinical roles do not identify physiotherapy as their 
profession when joining professional organisations. 
However, this does not appear to provide a solid explanation 
for the lack of physiotherapy-led presentations at national 
conferences identiﬁed in recent years. It also fails to explain 
the imbalance between representation of physiotherapists 
and other health professionals in this arena.
What can we do
Physiotherapy organisations, academic institutions, 
and therapists could develop strategies to increase the 
engagement of physiotherapists in cardiology research. 
Some simple strategies could include the implementation of 
a mentoring system designed to link physiotherapists with 
established research backgrounds and clinicians working in 
the management or prevention of cardiac disease. Greater 
mentorship of postgraduate physiotherapy research on 
cardiac topics is also needed in physiotherapy schools. The 
establishment of more frequent communication between 
clinical and research physiotherapists, via bodies such as 
Cardiorespiratory Physiotherapy Australia, CSANZ, and 
ACRA may also inspire clinicians to consider research 
in this area. Funding and academic opportunities in the 
area of cardiovascular disease management are extensive. 
Exploration of these opportunities by physiotherapists would 
be fruitful for individual physiotherapists, the profession 
and, ultimately and most importantly, for patients. Research 
opportunities are widely available and physiotherapists are 
ideally positioned to take a leadership role in the future 
evolution of cardiac management.
Conclusions
In summary, cardiac disease is a leading international health 
problem. Despite physiotherapists being ideally trained with 
relevant clinical experience there appears to be a general 
lack of engagement with cardiology research. The problem 
manifests across a range of domains including professional 
membership, active participation in national conferences, 
and publication of research in the area of cardiovascular 
disease. The expertise and capacity of physiotherapists 
coupled with extensive career opportunities in the area of 
cardiology research presents a range of opportunities for 
physiotherapists to explore.
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